Randomized, Double-Blind, Vehicle-Controlled, Multicenter Safety and Efficacy Study of Intraprostatic PRX302 for LUTS BPH

Clinical trial NCT01966614 · COMPLETED

Trial details

NCT number: NCT01966614
Sponsor: Sophiris Bio Corp
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Benign Prostatic Hyperplasia

Start date: 2013-10-01
Primary completion: 2015-12-01
Enrollment: 479

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.